Zurich-Schlieren, Switzerland

Mischa Roland Muller

USPTO Granted Patents = 4 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2016-2023

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Mischa Roland Muller: Innovator in Binding Molecule Technology

Introduction

Mischa Roland Muller is a notable inventor based in Zurich-Schlieren, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of binding molecules. With a total of four patents to his name, Muller has established himself as a key figure in his area of expertise.

Latest Patents

Muller's latest patents include a groundbreaking invention related to single domain binding molecules. The invention provides a specific binding molecule characterized by the structure FW1-CDR1-FW2-HV2-FW3a-HV4-FW3b-CDR3-FW4. This structure includes Framework Regions FW1, FW2, FW3a, FW3b, and FW4, as well as Complementarity Determining Regions CDR1 and CDR3, and Hypervariable Regions HV2 and HV4. The amino acid sequences defined in this invention offer a high affinity anti-human serum albumin (HSA) binding domain.

Career Highlights

Throughout his career, Muller has worked with esteemed organizations, including the University Court of the University of Aberdeen and Elasmogen Limited. His work has focused on advancing the understanding and application of binding molecules in various scientific fields.

Collaborations

Muller has collaborated with several professionals in his field, including Caroline Barelle and Jack Bikker. These collaborations have contributed to the development of innovative solutions in biotechnology.

Conclusion

Mischa Roland Muller is a prominent inventor whose work in binding molecule technology has the potential to impact various applications in biotechnology. His patents and collaborations reflect his commitment to advancing scientific knowledge and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…